Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol vs Verapamil in Symptomatic Non‑obstructive HCM
2024-515346-17-00Phase 4Authorised
- Sponsor
- Central Denmark Region
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Bisoprolol sequence, Verapamil sequence and Placebo sequence (3 arms). Primary endpoints: Maximal oxygen consumption (VO2 max), Left ventricular end-diastolic volume (LVvol) and 1 more. Planned start Jul 2024; status: authorised.
02
Drugs
bisoprololverapamil
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2024-515346-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515346-17-00.